Poster Presentations

Title: Efficacy and Safety of Insulin Glargine 300 U/mL (Gla-300) Versus Insulin Icodec in People with Type 2 Diabetes (PWT2D): A Systematic Literature Review and Network Meta-Analysis

AUTHORS: Ritzel R, Gomez-Peralta F, Napoli R, Ratzki-Leewing A, Mabunay MA, Szigeti M, Sanyal S, Alvarez A, Wan V, Giorgino F.

Conference: ADA, New Orleans, USA, June 5-8 2026

Title: Breaking Barriers in Cancer Immunotherapy: Mechanistic Insights into Resistance and Implications for Health Economics and Outcomes Research (HEOR) and Value Assessment

AUTHORS: Pushkarna D, Nazar G, Pourrahmat MM, Del Aguila M, Collet JP.

Conference: ISPOR Philadelphia, USA, May 17-20, 2026

Title: Global Landscape of Artificial Intelligence in Health Technology Assessment: Trends, Governance, and Emerging Practices

AUTHORS: Ting E, Badin M, Vuong V, Gaind N, Pourrahmat MM, Ivkovic L, Haugli-Stephens T, Jacob J, Fazeli MS.

Conference: ISPOR Philadelphia, USA, May 17-20, 2026

Title: Evolution of FDA Companion Diagnostics: 25 Years of Growth, Consolidation, and Technological Shift

AUTHORS: Shajarizadeh A, Fazeli MS.

Conference: ISPOR Philadelphia, USA, May 17-20, 2026

Title: Evolving Cost-Effectiveness Thresholds for Decision-Making at NICE: Changes in the Base Threshold and Use of Higher Thresholds in Special Cases

AUTHORS: Shajarizadeh A, Gaind N, Ivkovic L, Balasubramanian G, Fazeli MS.

Conference: ISPOR Philadelphia, USA, May 17-20, 2026

Title: Decoding the Predictive Role of Complete Response/Remission Rate (CR) for Overall Survival (OS) in Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)

AUTHORS: Serafini P, Fazeli MS, Pourrahmat MM, Kurt M.

Conference: ISPOR Philadelphia, USA, May 17-20, 2026

Title: Evaluating Individual-level Association Between Radiographic Progression-free Survival (PFS) and Overall Survival (OS) in Metastatic Hormone-sensitive Prostate Cancer (mHSPC): An Indirect Illness-death Modeling Approach

AUTHORS: Serafini P, Fazeli MS, Pourrahmat MM, Kurt M.

Conference: ISPOR Philadelphia, USA, May 17-20, 2026

Title: Progression-Free Survival as a Surrogate End Point for Overall Survival in the First-Line Setting Among Patients With Metastatic Triple-Negative Breast Cancer

AUTHORS: Punie K, Hurvitz SA, Dasgupta A, Kaushik A, Lai C, Padman P, Sjekloca N, Amzal B, Serafini P, Nazar G.

Conference: ESMO Breast Cancer, Berlin, Germany, May 6-8, 2026

Title: Correlation of Intermediate Clinical Endpoints for Overall Survival in Localized or Locally Advanced Prostate Cancer: Analysis of Individual Real-World Data

AUTHORS: Jahn B, Krabbe LM, Merseburger AS, Shore ND, De Solda F, Nair S, Price M, Sacchi E, Schaeffer M, Tang A, McCallion J, Lin X, McCarthy SA, Mundle SD, Wan V, Siebert U

Conference: ISPOR EU, November 9-12, 2025

Title: Economic and Clinical Impact of Older Adult Vaccination with The Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Vaccine in Mexico

AUTHORS: Guajardo V, Kendall R, Gaind N, Ivkovic L, Kefalogianni R, Mendes D

Conference: ISPOR EU, November 9-12, 2025

Title: Role of PROs in HTA Decision Making across UK, Germany, France, Italy, and Spain (EU4 + UK)

AUTHORS: Pushkarna D, del Aguila M , Collet JP, Fazeli MS

Conference: ISPOR EU, November 9-12, 2025

Title: Role of Real-World Evidence (RWE) in Pricing and Reimbursement Decisions for Rare Disease Health Technology Assessment (HTA) Submissions across EU4 + UK

AUTHORS: Pushkarna D, Kaur R, Fazeli MS

Conference: ISPOR EU, November 9-12, 2025

Title: Effective Use of Reconstructed Survival Data for Individual-Level Correlation Assessment in Oncology: A Case Study in Metastatic-Hormone Sensitive Prostate Cancer (mHSPC)

AUTHORS: Serafini P, Wan V, Fazeli MS, Kurt M

Conference: ISPOR EU, November 9-12, 2025

Title: Exploring the Association Between Treatment Effects on Cure Rates and Overall Survival (OS) in Resected Stage II/III Melanoma: A Correlation Meta Analysis (CMA) of Randomized Controlled Trials (RCTs)

AUTHORS: Serafini P, Wan V, Fazeli MS, Kurt M

Conference: ISPOR EU, November 9-12, 2025

Title: Empirical Comparison of Four Approaches for Generating Confidence Intervals Around Weighted Trial-Level Correlation

AUTHORS: Serafini P, Wan V, Fazeli MS, Kurt M

Conference: ISPOR EU, November 9-12, 2025

Title: Real-World Data for External Controls: Insights from EMA Regulatory Submissions

AUTHORS: Collet JC, Collet JP, Shouman W, Fazeli MS

Conference: ISPOR EU, November 9-12, 2025

Title: Olezarsen and plozasiran in the treatment of familial chylomicronemia syndrome (FCS): Results from a matching-adjusted indirect comparison (MAIC)

AUTHORS: Kessler AS, Serafini P, Pushkarna D, Zhou J, Baum S, Tsimikas S, Llonch MV

Conference: AMCP Nexus, October 27-30, 2025

Title: Literature Review of Safety Outcomes in Chronic Lymphocytic Leukemia (CLL): First-line (1L) Fixed Duration and Monotherapy Treatment Options in Canada​

AUTHORS: Vuong V, Kasireddy E, May JR, Collet J, Pourrahmat M, Fazeli MS, Dutta N, Kim C​

Conference: CAPT Toronto, Ontario, September 22-23, 2025

Title: Clinical and Economic Impact of Maternal Vaccination with Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Vaccine in Peru

AUTHORS: Bolanos R, Perata M, Kendall R, Ivkovic L, Anand M, Balasubramanian G, Kefalogianni R, Mendes D

Conference: 6th ESCMID Conference on Vaccines 2025, September 10th -13th, Lisbon

Title: Association Between Autoimmune Diseases And Development Of Autoimmune Type 1 Diabetes (T1D): A Targeted Literature Review (TLR)

AUTHORS: Wilson L, Hanna M, Gaind N, Pushkarna D, Breznen B

Conference: ADA 2025, June 20-23, Chicago

Title: Clinical and Economic Benefits of Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Vaccine for Prevention of RSV Infections Among Older Adults: A Cost-Effectiveness Analysis for Singapore

AUTHORS: Thakkar K, Kendall R, Gaind N, Ivkovic L, Balasubramanian G, Kefalogianni R, Zhang J, See KC, Lay-Hoon Kwa A, Mendes D

Conference: Asia Pneumonia Summit & Master Class in Vaccinology 2025 -Taipei, Taiwan -June 14-15, 2025

Title: Predictive Value of Intermediate Endpoints for Overall Survival in High-Risk Localized and Locally Advanced Prostate Cancer.

AUTHORS: Siebert U, De Solda F, Hofer K, McCallion J, McCarthy SA, Mundle SD, Pourrahmat MM, Wan V, Jahn B.

Conference: HTAi 2025 Annual Meeting; June 14-18, 2025; Buenos Aires, Argentina

Title: Economic and Clinical Benefits of Bivalent RSVPreF Maternal Vaccine for Prevention of RSV in Infants: A Cost-Effectiveness Analysis for Hong Kong

AUTHORS: Wong V, Fung M, Kendall R, Ivkovic L, Law AW, Mendes D

Conference: ESPID 2025, May 26-30

Title: Assessing the Impact of PD-L1 and BRAF Biomarkers on Long-Term Survivorship Rates Among Treatment-Naive Advanced Melanoma Patients Receiving Immune Checkpoint Inhibitors

AUTHORS: Kurt M, Serafini P, Wan V, Fazeli MS, Collet JP

Conference: ISPOR – May 13-16, 2025

Title: Evaluating the Application of GPT-4o and Retrieval-Augmented Generation (RAG) for Assessing Risk of Bias and Study Quality in Systematic Literature Reviews (SLRs): Preliminary Findings from a Comparative Study

AUTHORS: Kasireddy E, Chow C, Pourrahmat MM, Collet JP, Collet J, Fazeli MS

Conference: ISPOR – May 13-16, 2025

Title: The Inflation Reduction Act: Evaluating Impact on Medicare Drug Pricing, Innovation, and Access to Therapies

AUTHORS: Pushkarna D, Fazeli MS, del Aguila M, Pourrahmat MM

Conference: ISPOR – May 13-16, 2025

Title: Adapting Global Cost-Effectiveness Models for Low- and Middle-Income Countries: Key Learnings and Challenges Addressed

AUTHORS: Kendall R, Ivkovic L, Gaind N

Conference: ISPOR – May 13-16, 2025

Title: Artificial Intelligence Integration in Health Technology Assessments: A Review of Global Policies and Practices

AUTHORS: Ting E, Badin M, Gaind N, Hofer K, Pourrahmat MM, Ivkovic L, Haugli-Stephens T, Jacob J, Fazeli MS

Conference: ISPOR – May 13-16, 2025

Title: Collaborations Between Pharma and Digital Health Startups: Advancing Innovation and Reimbursement in Digital Health Technologies

AUTHORS: Pushkarna D, Kaur R, del Aguila M, Fazeli MS

Conference: ISPOR – May 13-16, 2025

Title: Factors Associated with Successful Implementation of Value-Based Agreements and Barriers for Their Adoption in the United States

AUTHORS: Pushkarna D, Shouman W, Fazeli MS, del Aguila M, Pourrahmat MM

Conference: ISPOR – May 13-16, 2025

Title: Do Lifetables Overestimate Non-Cancer-Specific Survival in Oncology? A Case Study From Treatment-Naïve Advanced Melanoma

AUTHORS: Kurt M, Serafini P, Wan V, Fazeli MS, Collet JP

Conference: ISPOR – May 13-16, 2025

Title: Real-World Evidence in FDA and EMA Regulatory Reviews: Insights on Its Role in Submission Packages and Approvals

AUTHORS: Hernandez R, Pugeat A, Collet J, Grancha ML, Fazeli MS, Hofer K, Collet JP.

Conference: ISPOR – May 13-16, 2025

Title: Real-world effectiveness and quality of life outcomes of tildrakizumab for moderate-to-severe plaque psoriasis in the United States: A systematic literature review and meta-analysis

AUTHORS: Gottlieb S, Farberg AS, Bhatia N, Fazeli MS, Hofer K, Lam O, Barghout V, Mathew J, Ferro T

Conference: AMCP – March 31-April 3, 2025

Title: Misdiagnoses of Autoimmune Type 1 Diabetes (T1D) or Latent Autoimmune Diabetes in Adults (LADA) as Type 2 Diabetes (T2D) in Adults: A Systematic Literature Review (SLR)

AUTHORS: Wilson L, Hanna M, Nazar G, Pushkarna D, Breznen B

Conference: AMCP March 31-April 3, 2025

Title: Comparative efficacy and safety of low-dose vs. high-dose bevacizumab in ovarian cancer: a systematic literature review and indirect treatment comparison.

AUTHORS: Ethier JL, Shephard C, Granados DP, Dutta N, Qadeer R, Ahmad S, Kasireddy E, Pourrahmat MM, Fazeli MS

Conference: SGO Annual Meeting on Women’s Cancer, March 14-17, 2025.

Title: Can overall survival (OS) benefit be predicted from improvements in progression-free survival (PFS) for previously untreated metastatic colorectal cancer (mCRC)?

AUTHORS: Roodhart JML, Dave K, Dixon M, Kurt M, Pushkarna D, Pourrahmat MM, Fazeli MS

Conference: ASCO GI, January 23-25, 2025.

Title: Evaluating Reimbursement Pathway of Digital Health Technologies across Five European Countries

AUTHORS: Pushkarna D, Fazeli MS, del Aguila M, Anand MS

Conference: ISPOR Europe, November 17-20, 2024

Title: Overall Survival and Quality of Life of Glioblastoma Patients According to MGMT Methylation Status: Real-World Data Analysis

AUTHORS: Wan V, Shouman W, Collet JP, Kouser H, Stuhlmiller TJ, del Aguila M

Conference: ISPOR Europe, November 17-20, 2024

Title: Performance-Based vs. Finance-Based Managed Entry Agreements: Global Trends and Challenges

AUTHORS: Pushkarna D, Fazeli MS, del Aguila M, Pourrahmat MM

Conference: ISPOR Europe, November 17-20, 2024

Title: Evaluating the Performance of GPT-4o and Retrieval-Augmented Generation in Extracting Data from Journal Articles: A Comparative Study

AUTHORS: Huang WH, Poojary V, Kasireddy E, Fazeli MS

Conference: ISPOR Europe, November 17-20, 2024

Title: Evaluating a Large Language Model Approach for Systematic Literature Review Screening with Domain Expert Input

AUTHORS: Huang WH, Poojary V, Hofer K, Fazeli MS

Conference: ISPOR Europe, November 17-20, 2024

Title: Incidence and prevalence of idiopathic pulmonary fibrosis: a systematic literature review and meta-analysis

AUTHORS: Golchin N, Lesperance T, Scheuring J, Wan V, Hofer K, Collet JP, Patel A, Elpers B

Conference: ISPOR Europe, November 17-20, 2024

Title: Incidence and prevalence of progressive pulmonary fibrosis (PPF) other than idiopathic pulmonary fibrosis: a systematic literature review and meta-analysis

AUTHORS: Golchin N, Lesperance T, Scheuring J, Wan V, Hofer K, Collet JP, Elpers B, Patel A

Conference: ISPOR Europe, November 17-20, 2024

Title: An Ensemble Approach to Predicting Overall Survival Benefit Jointly From Multiple Surrogate Endpoints in Oncology: A Case Study in Previously Untreated Metastatic Melanoma

AUTHORS: Kurt M, Serafini P, Pourrahmat MM, Wan V

Conference: ISPOR Europe, November 17-20, 2024

Title: Economic and Clinical Benefits of Bivalent RSVPreF Maternal Vaccine for Prevention of RSV in Infants: A Cost-Effectiveness Analysis for Mexico

AUTHORS: Huerta JL, Kendall R, Ivkovic L, Law AW, Mendes D

Conference: ISPOR Europe, November 17-20, 2024

Title: Prevalence, Incidence, and Definition of Severe Hypertriglyceridemia: A Comprehensive Review and Weighted Summary

AUTHORS: Baass A, Paquette M, Lam O, Hofer K, Collet J, McClain M

Conference: Cardiometabolic Health Congress, October 17-19, 2024

Title: A systematic literature review and meta-analysis of the real-world effectiveness, quality of life, and safety of tildrakizumab for moderate-to-severe plaque psoriasis.

AUTHORS: Gottlieb S, Farberg AS, Bhatia N, Fazeli MS, Hofer K, Lam O, Barghout V, Mathew J, Ferro T

Conference: AMCP Nexus, October 14-17, 2024

Encore:

  • Fall Clinical Dermatology Conference, October 24-27, 2024
  • Winter Clinical Hawaii, February 14 – 19, 2025
  • Music City SCALE (Symposium for Cosmetic Advances and Laser Education), May 14–18, 2025

Title: Comparative Efficacy and Safety of Tildrakizumab for Moderate-to-Severe Plaque Psoriasis: A Systematic Literature Review (SLR) and Network Meta Analysis (NMA).

AUTHORS: Lebwohl M, Carvalho A, Asahina A, Zhang J, Fazeli MS, Kasireddy E, Serafini P, Ferro T, Gogineni R, Thaçi D.

Conference: EADV Congress 2024. October 14-17, 2024

Title: Using Real-World Evidence for Clinical Drug Development to Address the Gap Between Marketing and Authorization and Reimbursement in European Countries

AUTHORS: Hernandez, R., Pugeat, A., Shouman, W., Pushkarna, D., Collet, J.-P. and Carita, P.

Conference: ISPE August 24-28 2024

Title: Systematic Review and Indirect Treatment Comparison of the Efficacy of Tildrakizumab vs Guselkumab or Risankizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis

AUTHORS: Abu-Hilal M, Serafini P, Balasubramanian G, Chan P, Ferro T.

Conference: Canadian Dermatology Conference. June 26-29, 2024.

Title: 1880-LB: Efficacy and Safety of iGlarLixi vs. IDegAsp in Non-Asian People with Type 2 Diabetes Inadequately Controlled with Basal Insulin—A Systemic Literature Review and Network Meta-analysis

AUTHORS: Philip Home; Felipe Lauand, Khier Djaballah; Francois Bourhis; Xuan Li; Khadija Hafidh; Roopa Mehta; Khadra Faraoun; Inan Anaforoglu; Mir-Masoud Pourrahmat

Conference: American Diabetes Association’s 84th Scientific Sessions. June 21–24, 2024

Title: A systematic literature review and meta-analysis of the real-world effectiveness, quality of life, and safety of tildrakizumab for moderate-to-severe plaque psoriasis.

AUTHORS: Scott Gottlieb, Aaron S. Farberg, Neal Bhatia, Mir Sohail Fazeli, Kimberly Hofer, Otto Lam, Vicki Barghout, Jacob Mathew, Thomas Ferro

Conference: SCALE. May 15-19, 2024

Title: Prevalence and incidence of dilated cardiomyopathy in the United States, France, Germany, Italy, Spain, and the United Kingdom: a systematic literature review

AUTHORS: Michael C. Myers, Amanda Berge, Yue Zhong, Sonomi Maruyama, Cindy Bueno, Arnaud Bastien, Kimberly Hofer, Ramandeep Kaur, Mir Sohail Fazeli, Negar Golchin

Conference: European Society of Cardiology Heart Failure. May 11-14, 2024

Title: Economic Burden and Healthcare Resource Utilization in Patients with Psoriatic Arthritis (PsA): A Systematic Literature Review

AUTHORS: Varga S, Walia S, Zema C, Pushkarna D, Dahan S, Fazeli MS, Choi J, Merola J

Conference: ISPOR 2024, May 5-8, 2024

Title: Economic Burden and Healthcare Resource Utilization in Patients with Systemic Lupus Erythematosus (SLE): A Systematic Literature Review (SLR)

AUTHORS: Choi J, Pomponi S, Andonova A, Pushkarna D, Fazeli MS, Clarke AE

Conference: ISPOR 2024, May 5-8, 2024

Title: Predicting Overall Survival (OS) Benefit in Previously Untreated Metastatic Melanoma From Improvements in Response Outcomes: A Correlation Meta-Analysis of Randomized Controlled Trials (RCTs)

AUTHORS: Leung L, Serafini P, Srinivasan S, Ejzykowicz F, Pourrahmat MM, Moshyk A, Kurt M

Conference: ISPOR 2024, May 5-8, 2024

Title: Prevalence of Genetic Dilated Cardiomyopathy: A Systematic Literature Review

AUTHORS: Michael C. Myers, Yue Zhong, Sonomi Maruyama, Cindy Bueno, Arnaud Bastien, Boris Breznen, Mir Sohail Fazeli, Negar Golchin

Conference: EPI|Lifestyle Scientific Sessions 2024, March 18–21, 2024

Title: Systematic literature review (SLR) of the sex-specific epidemiological burden of Psoriatic Arthritis (PsA) disease.

AUTHORS: Joseph F Merola, Stefan Varfa, Robert Carroll, Wei-Hua Huang, Carla Zema, Divya Pushkarna, Stephanie Dahan, Jiyoon Choi

Conference: AAD Annual Meeting, March 8-12, 2024

Title: Epidemiology, Economic Burden, and Humanistic Burden in Multiple Sclerosis Spasticity (MSS): A Systematic Literature Review (SLR)

AUTHORS: Drachenberg C, Nazar G, Pushkarna D, Viswanathan H, Fazeli MS

Conference: ISPOR EU 2023, November 12-15, 2023

Title: Recurrence-Free Survival (RFS) as a Surrogate Endpoint (SE) for Overall Survival (OS) in Resected Stage II/III Melanoma: A Correlation Meta-Analysis of Randomized Controlled Trials (RCTs)

AUTHORS: Leung L, Kirkwood J, Srinivasan S, Dyer M, Qian A, Pourrahmat MM, Kasireddy E, May JR, Moshyk A, Kurt M

Conference: ISPOR EU 2023, November 12-15, 2023

Title: Patient-Centric-Approach and Personalized Clinical Trials to Increase Patients Participation in Drug Development: Insight from a Targeted Literature Review (TLR)

AUTHORS: Collet JP, Shouman W, Hofer K, Pourrahmat MM, Maposa P, Fazeli MS

Conference: ISPOR EU 2023, November 12-15, 2023

Title: Follow the Money: Reporting Public Contributions and Incentives on Research and Development Programs for Agenzia Italiana Del Farmaco (AIFA; ITALIAN MEDICINES AGENCY)

AUTHORS: Pourrahmat MM, Maposa P, del Aguila M, Fazeli MS

Conference: ISPOR EU 2023, November 12-15, 2023

Title: Prevalence and incidence of Sjögren’s disease: A systematic literature review.

AUTHORS: Jiyoon Choi, Kimberly Hofer, Nishu Gaind, Mir Sohail Fazeli, Robert Carroll, Antoine Sreih, Antonia Christodoulou

Conference: ACR Convergence, November 10-15, 2023

Title: Recurrence-Free Survival (RFS) As a Surrogate Endpoint for Overall Survival (OS) in Adults with Early-Stage Hepatocellular Carcinoma (HCC): A Correlation Meta-Analysis of Randomized Controlled Trials (RCTS)

AUTHORS: Leung L, Singh P, Ademisoye E, Hofer K, Qian A, Kim I

Conference: ISPOR US 2023, May 7-10 2023

Title: Evaluating Disease-Free Survival (DFS) As a Surrogate Endpoint (SE) for Overall Survival (OS) in Muscle-Invasive Urothelial Carcinoma (MIUC): An Analysis of Surveillance, Epidemiology, and End Results (SEER)-Medicare Data

AUTHORS: Leung L, Kanters S, Pourrahmat MM, Friedman H, Navaratnam P, Reardon G, Patel M, Teitsson S, Kurt M, Lotan Y

Conference: ISPOR US 2023, May 7-10 2023

Title: HBA1C Reduction with Digital Health Devices in Type 2 Diabetes (T2DM): A Meta-Analysis of Randomized Controlled Trials

AUTHORS: Lee F, Han-Burgess E, Kennedy A, Serafini P, Pourrahmat MM, Breznen B.

Conference: ISPOR US 2023, May 7-10 2023

Title: I6 – The clinical burden in patients with multivessel disease post-acute myocardial infarction: A systematic literature review

AUTHORS: Bahit M, Korjian S, Daaboul Y, Chi G, Kalayci A, Gabriel S, Cupples G, Fazeli M, Shaunik A, Gibson C.

Conference: AMCP 2023, 21-24 March 2023

Title: I5 – Systematic literature review assessing the economic and humanistic burden of multivessel disease in patients with acute myocardial infarction.

AUTHORS: Baim, Gabriel S, Cupples G, Fazeli MS, Shaunik A.

Conference: AMCP 2023, 21-24 March 2023

Title: I3 – Assessing the multifactorial aspects of patient adherence to secondary preventative pharmacological therapies after an acute coronary syndrome

AUTHORS: Korjian S, Shaunik A, Nara P, Pourrahmat M, Breznen B, Gibson C.

Conference: AMCP 2023, 21-24 March 2023

Title: The economic and humanistic burden of multivessel disease in acute myocardial infarction: a systematic review.

AUTHORS: Korjian S,  Bahit MC, Daaboul Y, Chi G, Karabay AK, Gabriel S, Cupples G, Fazeli MS, Shaunik A, Gibson C.

Conference: American College of Cardiology (ACC) 2023, 4-6 March 2023

Title: #959 Digital Interventions for Self-Management in Type 2 Diabetes Mellitus

AUTHORS: Lee FC, Han‐Burgess E, Kennedy A, Breznen B, Pourrahmat MM

Conference: ATTD 2023, 22-25 February 2023

Title: Disease-free survival (DFS) as a surrogate endpoint (SE) for overall survival (OS) in early-stage resected esophageal/gastroesophageal junction cancer (EC/GEJC): An analysis of SEER-Medicare data.

AUTHORS: Ajani JA, Leung L, Kanters S, Singh P, Kurt M, Kim I, Pourrahmat MM, Friedman HS, Navaratnam P , Reardon G

Conference: ASCO GI 2023, 19-21 January 2023

Title: Radiographic Progression-Free Survival (RPFS) as a Surrogate Endpoint for Overall Survival (OS) in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer (MCRPC): A Correlation Meta-Analysis.

AUTHORS: Leung L, Patel M, Teitsson S, Hofer K, Qian A, Kurt M

Conference: ISPOR Europe 2022, 6-9 November 2022

Title: Exploring Endpoint Correlation Between Progression Free Survival (PFS) and Overall Survival (OS) in Previously Untreated Metastatic Melanoma Using Pseudo Individual Patient Data (IPD).

AUTHORS: Kanters S, Kurt M, Moshyk A, Leung L

Conference: ISPOR Europe 2022, 6-9 November 2022

Title: A Systematic Literature Review (SLR) of Comparative Efficacy Measures in Randomized Controlled Trials (RCTS) of Adjuvant Treatment in Localized Renal Cell Carcinoma (RCC).

AUTHORS: Ejzykowicz F, Kurt M, Dyer M, May JR, Shouman W, Kasireddy E, Pourrahmat MM

Conference: ISPOR Europe 2022, 6-9 November 2022

Title: Humanistic Burden of Informal Caregivers of Children and Young Adults With Newly Diagnosed Type 1 Diabetes (T1D): A Systematic Literature Review (SLR).

AUTHORS: Allen V, Bascle S, Cherkas A, Kasireddy E, Min R, Pushkarna D, Pourrahmat MM, Mahieu A

Conference: ISPOR Europe 2022, 6-9 November 2022

Title: Clopidogrel monotherapy following dual antiplatelet therapy in patients with acute coronary syndrome post-drug-eluting stent implantation: a systematic review and direct/indirect treatment comparison.

AUTHORS: D Sibbing, J Shan, F Bourhis, K Hofer, E Kasireddy, A Qian, I Khan

Conference: ESC 2022, 26-29 August 2022

Title: Dronedarone versus sotalol in patients with atrial fibrillation: a systematic literature review and network meta-analysis.

AUTHORS: B Kreidieh, J P Singh, C Blomstrom-Lundqvist, M P Turakhia, A J Camm, M S Fazeli, C Crotty, P R Kowey

Conference: ESC 2022, 26-29 August 2022

Title: EP057 / #753 – Efficacy And Safety Of Gla-300 Versusideg/Asp In People With Type 2 Diabetes(PWT2D): A Systematic Literature Review and Indirect Treatment Comparison (ITC)

AUTHORS: L. Zeng, Y. Huang, E. Shojaei, S. Behyan, P. Guyot, W. Landgraf.

Conference: Advanced Technologies & Treatments for Diabetes Conference (ATTD), 2022, April 27th-30th.

Title: Evaluating The Factors Associated With Patient Adherence And Persistence To Pharmacological Therapies After An Acute Coronary Syndrome

AUTHORS: Korjian S, Shaunik A, Nara P, Pourrahmat MM, Breznen B, Gibson CM

Conference: Quality of Care and Outcomes Research Scientific Sessions (QCOR), 2022, May 13th-14th.

Title: Determinants of adherence/persistence to positive airway pressure therapy in patients with obstructive sleep apnoea.

AUTHORS: R. Saad, V.K. Somers, G.S.Parks, D. Pushkarna, Fazeli MS, J. Black.

Conference: World Sleep Congress, 2022, March 11th-16th

Title: Indirect treatment comparison of efficacy and safety of insulin glargine 300U/mL with once-daily-insulin premix in T2DM.

AUTHORS: R. Ritzel, S. Ghosh, R. Emral, R. Malek, R. Malik, L. Zeng, Y. Huang, M.A. Mabunay, W. Landgraf, P. Guyot, E. Schenk, D. Pushkarna.

Conference: IDF 2021, December 6th-11th, 2021.

Title: Progression-Free Survival (PFS) As a Surrogate Endpoint for Overall Survival (OS) in Previously Untreated Advanced Melanoma: A Correlation Meta-Analysis of Randomized Controlled Trials (RCTS)

AUTHORS: Leung L, Chou E, Kurt M, Moshyk A, Hamilton M, Pourrahmat MM, Kanters S.

Conference: ISPOR EU 2021, November 30th-December 3rd, 2021.

Title: Surrogate Endpoints for Overall Survival (OS) in Advanced Melanoma: A Targeted Literature Review (TLR) of Correlation Meta-Analyses

AUTHORS: Pourrahmat MM, Leung L, Kurt M, Chou E, Kanters S, Moshyk A, Hamilton M.

Conference: ISPOR EU 2021, November 30th-December 3rd, 2021.

Title: Treatment outcomes in patients (pts) with melanoma brain metastases (MBM) undergoing systemic therapy: a systematic literature review (SLR) and meta-analysis (MA) of real-world evidence (RWE).

AUTHORS: Long G, Tawbi H, Meyer N, Breznen B, Vyas C, Leung L, Moshyk A, Pushkarna D, Thakkar P, Fazeli MS, Kotapati S, Schadendorf D.

Conference: ESMO 2021, September 16th-21st, 2021.

Title: Efficacy and Safety of iGlarLixi vs IDegAsp: Systematic Review and Indirect Treatment Comparison (ITC).

AUTHORS: Home P, Mehta R, Hafidh K, Gurova O, Alvarez A, Serafini P, Pourrahmat MM.

Conference: Virtual ADA 2021, June 25th-29th, 2021.

Title: Use of Chimeric Antigen Receptor T cell Therapies in Patients With Large B-cell Lymphoma in the Real-World Setting: Systematic Literature Review.

AUTHORS: Liu F, Hofer K, Ardekani G, Parker C

Conference: EHA 2021, June 9th-17th, 2021.

Title: Treatment outcomes in patients (pts) with melanoma brain metastases (MBM) treated with systemic therapy: A systematic literature review (SLR) and meta-analysis.

AUTHORS: Tawbi H, Long G, Meyer N, Breznen B, Vyas C, Leung L, Moshyk A, Pushkarna D, Thakkar P, Fazeli MS, Kotapati S, Schadendorf D

Conference: ASCO 2021, June 4th-8th, 2021.

Title: Analysis of Individual-Level Association of Progression-Free Survival (PFS) and Time to Treatment Failure (TTF) with Overall Survival (OS) for Previously Untreated Advanced Renal Cell Carcinoma Patients in the CheckMate 214 Trial

AUTHORS: Siliman G, Kanters S, Fazeli MS, Pourrahmat MM, Ejzykowicz F, Kurt M

Conference: Virtual ISPOR 2021, May 17th-20th, 2021.

Title: Understanding Hispanic/Latino participation in clinical trials and observational studies in the United States, and strategies to increase participation: A targeted literature review

AUTHORS: Ferri L, Kuri L, Ferri M, Dreyfus B, Doykos P, Andonova A, Hofer K, Fazeli MS

Conference: National Hispanic Medical Association, 24th Annual Conference. March 17th-20th, 2021.

Title: Indirect Costs of Oral Versus Non-Oral Therapies in Hematologic Malignancies: A Systematic Literature Review

AUTHORS: Fazeli MS., Pushkarna D., Howarth A., Hux M., Pourrahmat M-M., Chen C.

Conference: American Society of Hematology, Virtual. December 5th-8th, 2020.

Title: Effectiveness and Safety of Enoxaparin in Patients with Active Cancer and Venous Thromboembolism (VTE): A Systematic Literature Review

AUTHORS: Shan J, Sayre T, Hofer K, Shojaei E

Conference: ISTH 2020, July 12th-14th, 2020.

Title: Indirect Treatment Comparison (ITC) of IGlarLixi vs. IDegLira in Adults Inadequately Controlled by GLP-1 Receptor Agonists (GLP-1RAs)

AUTHORS: Home PD., Aroda VR., Fazeli MS., Whittington C., Goswami H., Shaunik A., Pourrahmat MM., Blonde L., Kalra S

Conference: ADA 2020, June 12th-16th 2020.

Title: Health State Utility Values Across Cancer Types and Stages- A Systematic Literature Review

AUTHORS: Pourrahmat MM., Kansal AR., Chung KC., Hux M., Howarth A., Fazeli MS.

Conference: ISPOR 2020, Orlando, FL, USA. May 18th-20th, 2020.

Title: Treatment Patterns in High-Risk, Bacille Calmette-Guérin Unresponsive Non-Muscle Invasive Bladder Cancer Patients- A Systematic Literature Review.

AUTHORS: Broughton E., Chun D., Gooden K., Hofer K., Fazeli MS.

Conference: ISPOR 2020, Orlando, FL, USA. May 18th-20th, 2020.

Title: Placebo Effect in Knee Osteoarthritis- A Targeted Literature Review on The Challenges, Hypotheses, And Potential Solutions.

AUTHORS: Hofer K., Lin M., Pourrahmat MM., Fazeli MS.

Conference: ISPOR 2020, Orlando, FL, USA. May 18th-20th, 2020.

Title: Cardiovascular Disease in Rheumatoid Arthritis: Risk Factors and the Role of Auto-antibodies.

AUTHORS: Ferri L., Crocket G., Kuang Y., Breznen B., Fazeli MS.

Conference: American College of Rheumatology/ Association of Rheumatology Professionals (ACR/ARP) Annual Meeting, Atlanta, GA, USA. November 8th – 13th, 2019.

Title: Prognostic Factors and Clinical Outcome Modifiers in Patients with Rheumatoid Arthritis: A Review.

AUTHORS: Ferri L., Crocket G., Han X., Breznen B., Fazeli MS.

Conference: American College of Rheumatology/ Association of Rheumatology Professionals (ACR/ARP) Annual Meeting, Atlanta, GA, USA. November 8th – 13th, 2019.

Title: Epidemiology, Risk/Prognostic Factors, and Treatment Landscape in Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Systematic Literature Review.

AUTHORS: Han X., Ferri L., Crocket G., Fazeli MS.

American College of Rheumatology/ Association of Rheumatology Professionals (ACR/ARP) Annual Meeting, Atlanta, GA, USA. November 8th – 13th, 2019.

Title: The Effect of DMARDs on Cardiovascular Outcomes in Rheumatoid Arthritis: A Systematic Literature Review.

AUTHORS: Patel V., Ferri L., Han X., Mintzer L., Fazeli MS.

American College of Rheumatology/ Association of Rheumatology Professionals (ACR/ARP) Annual Meeting, Atlanta, GA, USA. November 8th – 13th, 2019.

Title: Abatacept in Early Rheumatoid Arthritis: A Systematic Literature Review and Network Meta-Analysis.

AUTHORS: Paul D., Ferri L., Crocket G., Mintzer L., Fazeli MS.

European League Against Rheumatism (EULAR) Annual Meeting, Madrid, Spain. June 12th–15th, 2019.

Title: Comparative Safety Of Abatacept And Other Non-tumor Necrosis Factor Inhibitors In Rheumatoid Arthritis: A Systematic Literature Review And Network Meta-analysis

AUTHORS: Paul D, Taylor B, Kuang Y, Fazeli MS

European League Against Rheumatism (EULAR) Annual Meeting, Madrid, Spain. June 12th–15th, 2019.

Title: The comparative effectiveness of treatments after chemoradiation therapy (CRT) for unresectable stage III non-small cell lung cancer (NSCLC): A network meta-analysis. 

AUTHORS: Dron L., Harari O., Fazeli MS., Zhang Y.

ISPOR 2019, New Orleans, LA, USA. May 18th–22nd, 2019.

Title: Humanistic and Economic Burdens of Triple-Negative Breast Cancer: A Literature Review. 

AUTHORS: Fu AZ., Breznen B., Fazeli MS., Hux M., Kumar N., Davis C.

ISPOR 2019, New Orleans, LA, USA. May 18th–22nd, 2019.

Title: Treatment landscape in triple negative breast cancer: A systematic literature review.

AUTHORS: Fu AZ., Kuang Y., Fazeli MS., Kumar N., Davis C.

ESMO Breast Cancer 2019, Berlin, Germany. May 2nd–4th, 2019.

Title: Comparative efficacy of consolidation therapy after chemoradiation therapy (CRT) in patients with unresectable, locally advanced non-small cell lung cancer (LA-NSCLC): a network meta-analysis.

AUTHORS: Husain F., Harari O., Fazeli M., Zhang Y.

ISPOR 23rd Annual International Meeting, Baltimore, Maryland, USA. May 19th–23rd, 2018.

Title: Prevalence and timing of de-escalation therapy from ticagrelor to clopidogrel in acute coronary syndrome patients: results of a meta-analysis.

AUTHORS: Angiolillo D., Paek D., Shah R., Fazeli MS., Girotra S.

American College of Cardiology 67th Annual Scientific Session & Expo 2018 (ACC 2018), Orlando, Florida, USA. March 10th–March 12th.

Title: Transparency matters: use of digital software platform in replicating systematic reviews.

AUTHORS: Husain F., Sayre T., Feinman T., Fazeli M., Kuang Y., del Aguila MA.

ISPOR 20thAnnual European Congress.Doctor Evidence LLC., Glasgow, Scotland. Nov. 4th–8th, 2017.